Literature DB >> 30680588

FDG atrial uptake is associated with an increased prevalence of stroke in patients with atrial fibrillation.

Mathieu Sinigaglia1,2,3, Besma Mahida4,5,6, Eve Piekarski4,5,6,7, Renata Chequer4,5,6, Nidaa Mikail4,5,6, Khadija Benali4,5,6, Fabien Hyafil4,5,6,7, Dominique Le Guludec4,5,6,7, François Rouzet4,5,6,7.   

Abstract

PURPOSE: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is associated with an increased risk of stroke. Indeed, silent AF is frequently identified in unexplained ischemic stroke. 18F-FDG-PET/CT is a powerful tool for assessing myocardial metabolic shift and inflammation, both potentially at stake in AF. This case-control study investigated whether AF could promote FDG uptake in atria after physiological myocardial glucose uptake suppression, and the potential relationship between FDG atrial uptake and prevalence of stroke.
METHODS: We retrospectively enrolled 128 patients (64 consecutive patients with AF and 64 without AF as the control group, matched for age and sex) who underwent 18F-FDG-PET/CT after a high-fat low-carbohydrate diet. We analyzed visual and quantitative FDG uptake parameters of the right and left atria (RA/LA) and the right and left appendages (RAA/LAA), and selected clinical features including history of stroke.
RESULTS: Diffuse right atrial uptake was present in a third of patients with AF and only two patients in the control group. FDG uptake intensity of both atria was significantly associated with the underlying heart rhythm. The occurrence of stroke was strongly associated with detectable atrial uptake in multivariate analysis, with an odds ratio superior to that of other known risk factors.
CONCLUSIONS: This study shows a significant correlation between FDG atrial uptake and AF. While inconsistent, this pattern seems to be associated with an increased prevalence of cardioembolic stroke.

Entities:  

Keywords:  Atrial fibrillation; FDG; Inflammation; Positron emission tomography (PET); Stroke

Year:  2019        PMID: 30680588     DOI: 10.1007/s00259-019-4274-6

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  34 in total

1.  PET demonstration of left atrial appendage in chronic atrial fibrillation.

Authors:  Ba D Nguyen
Journal:  Clin Nucl Med       Date:  2005-03       Impact factor: 7.794

2.  ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.

Authors:  Valentin Fuster; Lars E Rydén; David S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; Jean-Yves Le Heuzey; G Neal Kay; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; Samuel Wann; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffery L Anderson; Elliott M Antman; Jonathan L Halperin; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; Juan Luis Tamargo; José Luis Zamorano
Journal:  Circulation       Date:  2006-08-15       Impact factor: 29.690

Review 3.  Partial-volume effect in PET tumor imaging.

Authors:  Marine Soret; Stephen L Bacharach; Irène Buvat
Journal:  J Nucl Med       Date:  2007-05-15       Impact factor: 10.057

4.  Reprogramming of the human atrial transcriptome in permanent atrial fibrillation: expression of a ventricular-like genomic signature.

Authors:  Andreas S Barth; Sylvia Merk; Elisabeth Arnoldi; Ludwig Zwermann; Patrick Kloos; Mathias Gebauer; Klaus Steinmeyer; Markus Bleich; Stefan Kääb; Martin Hinterseer; Heike Kartmann; Eckart Kreuzer; Martin Dugas; Gerhard Steinbeck; Michael Nabauer
Journal:  Circ Res       Date:  2005-04-07       Impact factor: 17.367

5.  Increased FDG uptake in the wall of the right atrium in people who participated in a cancer screening program with whole-body PET.

Authors:  H Fujii; M Ide; S Yasuda; W Takahashi; A Shohtsu; A Kubo
Journal:  Ann Nucl Med       Date:  1999-02       Impact factor: 2.668

6.  Time course of atrial fibrillation-induced cellular structural remodeling in atria of the goat.

Authors:  J Ausma; N Litjens; M H Lenders; H Duimel; F Mast; L Wouters; F Ramaekers; M Allessie; M Borgers
Journal:  J Mol Cell Cardiol       Date:  2001-12       Impact factor: 5.000

7.  Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation.

Authors:  Wim Anné; Rik Willems; Tania Roskams; Paul Sergeant; Paul Herijgers; Patricia Holemans; Hugo Ector; Hein Heidbüchel
Journal:  Cardiovasc Res       Date:  2005-09-01       Impact factor: 10.787

8.  Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation.

Authors:  Dwayne S g Conway; Peter Buggins; Elizabeth Hughes; Gregory Y H Lip
Journal:  Am Heart J       Date:  2004-09       Impact factor: 4.749

9.  Induction of atrial natriuretic factor and myosin light chain-2 gene expression in cultured ventricular myocytes by electrical stimulation of contraction.

Authors:  P M McDonough; C C Glembotski
Journal:  J Biol Chem       Date:  1992-06-15       Impact factor: 5.157

Review 10.  Electrical, contractile and structural remodeling during atrial fibrillation.

Authors:  Maurits Allessie; Jannie Ausma; Ulrich Schotten
Journal:  Cardiovasc Res       Date:  2002-05       Impact factor: 10.787

View more
  3 in total

Review 1.  Series of myocardial FDG uptake requiring considerations of myocardial abnormalities in FDG-PET/CT.

Authors:  Ryogo Minamimoto
Journal:  Jpn J Radiol       Date:  2021-01-31       Impact factor: 2.374

2.  18F-fluorodeoxyglucose positron emission tomography for the detection of inflammatory lesions of the arterial vessel walls in Wistar rats.

Authors:  Shiwei Shen; Hongwei Li; Song Ge; Hongbo Huang; Hui Zhang; Feng Li; Yinbo Feng; Ling Wang; Xiaofeng Weng; Yun Lu; Zhenhai Shen
Journal:  Exp Ther Med       Date:  2021-02-19       Impact factor: 2.447

3.  Right Atrial Fluorodeoxyglucose Uptake Is a Risk Factor for Stroke and Improves Prediction of Stroke Above the CHA2DS2-VASc Score in Patients With Atrial Fibrillation.

Authors:  Bing Wang; Yiduo Xu; Peng Wan; Shan Shao; Feifei Zhang; Xiaoliang Shao; Jianfeng Wang; Yuetao Wang
Journal:  Front Cardiovasc Med       Date:  2022-07-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.